Legagneux V - Search Results

1

Correction: Proteomic screening identifies the zonula occludens protein ZO-1 as a new partner for ADAM12 in invadopodia-like structures.

Dekky B, Ruff M, Bonnier D, Legagneux V, Théret N. Dekky B, et al. Among authors: legagneux v. Oncotarget. 2018 Nov 6;9(87):35795. doi: 10.18632/oncotarget.26339. eCollection 2018 Nov 6. Oncotarget. 2018. PMID: 30515271 Free PMC article.

2

Proteomic screening identifies the zonula occludens protein ZO-1 as a new partner for ADAM12 in invadopodia-like structures.

Dekky B, Ruff M, Bonnier D, Legagneux V, Théret N. Dekky B, et al. Among authors: legagneux v. Oncotarget. 2018 Apr 20;9(30):21366-21382. doi: 10.18632/oncotarget.25106. eCollection 2018 Apr 20. Oncotarget. 2018. PMID: 29765546 Free PMC article.

3

A pipeline to create predictive functional networks: application to the tumor progression of hepatocellular carcinoma.

Folschette M, Legagneux V, Poret A, Chebouba L, Guziolowski C, Théret N. Folschette M, et al. Among authors: legagneux v. BMC Bioinformatics. 2020 Jan 14;21(1):18. doi: 10.1186/s12859-019-3316-1. BMC Bioinformatics. 2020. PMID: 31937236 Free PMC article.

4

Integration of miRNA-regulatory networks in hepatic stellate cells identifies TIMP3 as a key factor in chronic liver disease.

Azar F, Courtet K, Dekky B, Bonnier D, Dameron O, Colige A, Legagneux V, Théret N. Azar F, et al. Among authors: legagneux v. Liver Int. 2020 Aug;40(8):2021-2033. doi: 10.1111/liv.14476. Epub 2020 May 5. Liver Int. 2020. PMID: 32306499 Free article.

5

ADAM and ADAMTS Proteins, New Players in the Regulation of Hepatocellular Carcinoma Microenvironment.

Théret N, Bouezzedine F, Azar F, Diab-Assaf M, Legagneux V. Théret N, et al. Among authors: legagneux v. Cancers (Basel). 2021 Mar 29;13(7):1563. doi: 10.3390/cancers13071563. Cancers (Basel). 2021. PMID: 33805340 Free PMC article. Review.

6

ADAMTS12 is a stromal modulator in chronic liver disease.

Dekky B, Azar F, Bonnier D, Monseur C, Kalebić C, Arpigny E, Colige A, Legagneux V, Théret N. Dekky B, et al. Among authors: legagneux v. FASEB J. 2023 Nov;37(11):e23237. doi: 10.1096/fj.202200692RRRR. FASEB J. 2023. PMID: 37819632

7

3D culture of HepaRG cells in GelMa and its application to bioprinting of a multicellular hepatic model.

Cuvellier M, Ezan F, Oliveira H, Rose S, Fricain JC, Langouët S, Legagneux V, Baffet G. Cuvellier M, et al. Among authors: legagneux v. Biomaterials. 2021 Feb;269:120611. doi: 10.1016/j.biomaterials.2020.120611. Epub 2020 Dec 16. Biomaterials. 2021. PMID: 33385685 Free article.

8

Dual extraction of mRNA and lipids from a single biological sample.

Podechard N, Ducheix S, Polizzi A, Lasserre F, Montagner A, Legagneux V, Fouché E, Saez F, Lobaccaro JM, Lakhal L, Ellero-Simatos S, Martin PG, Loiseau N, Bertrand-Michel J, Guillou H. Podechard N, et al. Among authors: legagneux v. Sci Rep. 2018 May 4;8(1):7019. doi: 10.1038/s41598-018-25332-9. Sci Rep. 2018. PMID: 29728575 Free PMC article.

9

Generation of proliferating human adult hepatocytes using optimized 3D culture conditions.

Rose S, Ezan F, Cuvellier M, Bruyère A, Legagneux V, Langouët S, Baffet G. Rose S, et al. Among authors: legagneux v. Sci Rep. 2021 Jan 12;11(1):515. doi: 10.1038/s41598-020-80019-4. Sci Rep. 2021. PMID: 33436872 Free PMC article.

10

DMSO-free highly differentiated HepaRG spheroids for chronic toxicity, liver functions and genotoxicity studies.

Rose S, Cuvellier M, Ezan F, Carteret J, Bruyère A, Legagneux V, Nesslany F, Baffet G, Langouët S. Rose S, et al. Among authors: legagneux v. Arch Toxicol. 2022 Jan;96(1):243-258. doi: 10.1007/s00204-021-03178-x. Epub 2021 Nov 11. Arch Toxicol. 2022. PMID: 34762139 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

43 results

Search Page